Regulatory submissions of non-interventional post-authorisation safety studies - Volume 26, Issue

The post-authorisation safety study (PASS) is a pharmacovigilance activity often required as a post-marketing commitment to establish a safety profile or address specific safety concerns. An imposed PASS must be submitted in common technical…

The evolving landscape of medical education in oncology - Volume 21, Issue

The field of oncology is continuously evolving. The way in which cancer is diagnosed, staged, and managed has changed so much in the last decade, and awareness of the need for a ‘personalized medicine’ approach to patient management is growing. In…

Lay titles for clinical trials: A balancing act - Volume 27, Issue

With increasing transparency demands andthe new legal requirements for providingclinical trial information to lay readers, clinicaltrials need to be given titles that patients canunderstand and recognise. Trial titles informthe readers what the…

Social media scheduling: How not to spam your followers - Volume 30, Issue

Social media is, today, an indispensable part of networking and business. However, many professionals are still learning how to navigate the sea of social media. Big companies have a dedicated department, but small businesses, entrepreneurs, and…

President's Message - Volume 24, Issue

Dear EMWA Members, As we came together in the historic city of The Hague in November 2015 for another successful and enjoyable conference, we were particularly delighted to welcome our Benelux members who turned out in force. The usual EMWA…

EMWA social media team - Volume 23, Issue

Editorial - Volume 29, Issue

When we first sent out the call for papers for the Autumn 2020 issue of Medical Writing, there were only a few reports of a novel coronavirus. Today, of course, COVID-19 is a pandemic. Welcome to the “new normal” , where many of the routines,…

Editorial - Volume 29, Issue

Data are economic assets that power the so-called fourth industrial revolution. The healthcare industry is at the forefront of this “data economy”. Medical writers should understand how to use these data appropriately and responsibly. This issue of…

Omics in silico and other trends in biomedical research: Impact on how and what we write - Volume 28, Issue

Medical writers and communicators write about biomedical research. It follows that the latest trends in this field translate to new trends in medical writing. This article provides a peek into the latest breakthroughsand developments in biomedical…

Transferring regulation into practice: The challenges of the new layperson summary of clinical trial results - Volume 24, Issue

The new European Clinical Trials Regulation, published on 27 May 2014, requires sponsors to provide summary results of clinical trials in a format that is understandable to laypersons. The lay summary is to be made publicly available in the yet to…